Flautt Thomas, Valderrábano Miguel
Division of Cardiac Electrophysiology, Department of Cardiology, Houston Methodist DeBakey Heart and Vascular Center, Houston Methodist Hospital, Houston, TX, USA.
Division of Cardiac Electrophysiology, Department of Cardiology, Houston Methodist DeBakey Heart and Vascular Center, Houston Methodist Hospital, Houston, TX, USA.
Card Electrophysiol Clin. 2022 Dec;14(4):743-756. doi: 10.1016/j.ccep.2022.08.002.
Radiofrequency catheter ablation (RFCA) is the first-line therapy for treatment of drug refractory ventricular arrhythmias (VAs), however, creating a safe, transmural lesion can be difficult. Ethanol in the arterial system has been used as an adjunctive therapy to RFCA since 1986, but with limited use due to technical and efficacy limitations. Venous ethanol is emerging as powerful alternative.
射频导管消融术（RFCA）是治疗药物难治性室性心律失常（VAs）的一线疗法，然而，形成安全的透壁性损伤可能具有挑战性。自1986年以来，动脉系统中的乙醇一直被用作RFCA的辅助治疗，但由于技术和疗效限制，其应用有限。静脉注射乙醇正成为一种有力的替代方法。
